18 Recruiting Lung Cancer Phase 1 Clinical Trials
Active phase 1 studies for lung cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Lung Cancer studiesPhase 1 Studies for Lung Cancer
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
View Study & Checklist ➔A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
📍 Hoag Memorial Hospital Presbyterian — Newport Beach, California
View Study & Checklist ➔A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
📍 California Cancer Associates for Research and Excellence, Inc. (cCare) — Encinitas, California
View Study & Checklist ➔Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
📍 John Hopkins Medical Center — Baltimore, Maryland
View Study & Checklist ➔Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
📍 City of Hope Cancer Center — Duarte, California
View Study & Checklist ➔Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy
📍 Rutgers Cancer Institute — New Brunswick, New Jersey
View Study & Checklist ➔Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
📍 Stanford University — Stanford, California
View Study & Checklist ➔Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
📍 Royal University Hospital — Saskatoon, Saskatchewan
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
📍 The University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
📍 St. Paul's Hospital — Saskatoon, Saskatchewan
View Study & Checklist ➔Talazoparib and Thoracic RT for ES-SCLC
📍 Princess Margaret Cancer Center, University Health Network — Toronto, Ontario
View Study & Checklist ➔Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔